← Back to All Filings
United Therapeutics Director Files Form 144 to Sell $115K in Common Stock
UNITED THERAPEUTICS Corp
$UTHR144CIK: 0001082554
Subscribe to track UTHR
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Form 144 Notice of Proposed Sale of Securities Issuer: UNITED THERAPEUTICS Corp ($UTHR) Insider: NILDA MESA (Director) Shares Proposed for Sale: 228 Aggregate Market Value: $115,337.83 (~$505.87/share) Approximate Sale Date: 09/14/2026 Broker: Morgan Stanley Smith Barney LLC
Comprehensive Analysis
Form 144 Filing Overview: United Therapeutics Corp (UTHR)
Transaction Summary
- Filer: Nilda Mesa, Director
- Securities to be Sold: 228 shares of Common Stock
- Estimated Aggregate Market Value: $115,337.83
- Approximate Date of Sale: September 14, 2026
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
Source of Securities
- 130 Shares: Acquired on September 14, 2026, via Stock Option Exercise from the issuer (cash payment).
- 98 Shares: Acquired on July 9, 2026, via Restricted Stock vesting from the issuer.
Analysis & Impact
- Trading Significance: Low. The proposed sale represents 228 shares out of 42,890,692 shares outstanding (<0.001% of total shares).
- Past 3 Months Activity: No other sales reported in the preceding 3 months.
- Market Context: This transaction reflects routine equity compensation liquidation following an option exercise and restricted stock vesting.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.